A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging

Saudi Journal of Anaesthesia

Volumn 5, Issue 3, 2011, Pages 295-299

  Dave, Jaydev ^a   Vaghela, Sandip ^a  

^a M P SHAH MEDICAL COLLEGE   (India)

Author keywords

Dexmedetomidine; magnetic resonance imaging; propofol

Indexed keywords

DEXMEDETOMIDINE; PROPOFOL;

ANESTHESIA INDUCTION; ANESTHESIA LEVEL; ANESTHETIC RECOVERY; ARTICLE; BLOOD OXYGEN TENSION; BREATHING RATE; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART RATE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 80052480995     PISSN: 1658354X     EISSN: 09753125     Source Type: Journal    
DOI: 10.4103/1658-354X.84105     Document Type: Article

References (25)

1. Lawson GR. Sedation of children for magnetic resonance imaging. Arch Dis Child 2000;82:150-3.
2. Hasan RA, Shayevitz JR, Patel V. Deep sedation with propofol for children undergoing ambulatory magnetic resonance imagingof the brain: Experience from a pediatric intensive care unit. Pediatr Crit Care Med 2003;4:454-8.
3. Bluemke DA, Breiter SN. Sedation procedures in MR imaging: safety, effectiveness, and nursing effect on examinations. Radiology 2000;216:645-52. (Pubitemid 30660833)
4. Malviya S, Voepel LT, Eldevik OP, Rockwell DT, Wong JH, Tait AR. Sedation and general anaesthesia in children undergoing MRI and CT: adverse eventsand outcomes. Br J Anaesth 2000;84:743-8. (Pubitemid 30312044)
5. Dial S, Silver P, Bock K, Sagy M. Pediatric sedation for procedures titrated to desired degree of immobility results in unpredictabledepth of sedation. Pediatr Emerg Care 2001;17:414-20. (Pubitemid 34048997)
6. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000;59:263-8. (Pubitemid 30168513)
7. Shelly MP. Dexmedetomidine: A real innovation or more of thesame? Br J Anaesth 2001;87:677-8. (Pubitemid 33069553)
8. Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleeppromotingpathway to exert its sedative effects. Anesthesiology 2003;98:428-36. (Pubitemid 36592812)
9. Koroglu A, Demirbilek S, Teksan H, Sagir O, But AK, Ersoy MO. Sedative, hemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: Preliminary results. Br J Anaesth 2005;94:821-4. (Pubitemid 40754000)
10. Frankville DD, Spear RM, Dyck JB. The dose of propofol required to prevent children from moving during magneticresonance imaging. Anesthesiology 1993;79:953-8. (Pubitemid 23339054)
11. Usher GA, Kearney RA, Tsui BC. Propofol total intravenousanesthesia for MRI in children. Paediatr Anaesth 2005;15:23-8. (Pubitemid 40188788)
12. Voepel LT, Malviya S, Prochaska G, Tait RA. Sedation failures in children undergoing MRI and CT: Is temperament a factor? Paediatr Anaesth 2000;10:319-23. (Pubitemid 30331174)
13. Hall JE, Ulrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90:699-705. (Pubitemid 30117535)
14. Tobias JD, Berkenbosch JW. Initial experience with dexmedetomidinesin paediatric-aged patients. Paediatr Anaesth 2002;12:171-5. (Pubitemid 34146752)
15. Tobias JD, Berkenbosch JW, Russo P. Additional experience with dexmedetomidine in pediatric patients. South Med J 2003;96:871-5. (Pubitemid 38279587)
16. Triltsch AE, Welte M, Von Homeyer P, Grosse J, Genähr A, Moshirzadeh M, et al. Bispectral indexguided sedation with dexmedetomidine in intensive care: randomized, double blind, placebo-controlled phase II study. Crit Care Med 2002;30:1007-14. (Pubitemid 34508021)
17. Bloomfield EL, Masaryk TJ, Caplin A, Obuchowski NA, Schubert A, Hayden J, et al. Intravenous sedation for MR imaging of the brain and spine in children:pentobarbital versus propofol. Radiology 1993;186:93-7. (Pubitemid 23005471)
18. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperativesedation in the intensive care unit. Anaesthesia 1999;54:1136-42.
19. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasingplasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94. (Pubitemid 30620311)
20. Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patientsrequiring intensive care. Br J Anaesth 2002;88:669-75. (Pubitemid 34498595)
21. Kallio A, Scheinin M, Koulu M, Ponkilainen R, Ruskoaho H, Viinamäki O, et al. Effects of dexmedetomidine, a selective alpha2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther 1989;49:33-42. (Pubitemid 19195772)
22. Aun CS. New i.v. agents. Br J Anaesth 1999;83:29-41. (Pubitemid 29317501)
23. Tramer MR, Moore RA, McQuay HJ. Propofol and bradycardia:causation, frequency and severity. Br J Anaesth 1997;78:642-51.
24. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000;4:302-8.
25. Belleville JP, Wards DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in human: sedation, ventilation and metabolic rate. Anesthesiology 1992;77:1125-33. (Pubitemid 23001123)